Cook Enforcer Post-Market Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 211 participants.

Also called NCT03552289

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 211 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03552289
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03552289. Randomized; no masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2019-05-29 (actual). Results posted on 2020-08-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cook Enforcer Post-Market Study
Condition
End-Stage Renal Disease
Intervention (Device)
Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
Intervention (Device)
Conventional angioplasty balloon catheters
Lead sponsor
Cook Research Incorporated (class: industry)

Record details

Record id
cardio:ct-nct03552289
Content hash
f1278b3f212ec020bef257bf2fe745b358b74afde1eba1b00bff65f8d33c25d1